GenePlanet
PrivateLast Round
Series B
Jul 13, 2023
Total Funding Raised
$22.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
GenePlanet operates in Healthcare & Life Sciences and is based in Ljubljana. Its latest recorded funding round was a Series B round in July 2023.
GenePlanet is a biotechnology company that is a provider of innovative healthcare and lifestyle solutions based on preventive genetic testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenePlanet Comparables
Compare GenePlanet with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dante Labs | 81% | |
| LetsGetChecked | 78% | |
| Prenetics | 76% |
For institutional investors. Book with your work email.
GenePlanet Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 13, 2023 | ||||
| VC Round | Jul 9, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GenePlanet Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Designed Impact Ventures | Series B |
| BlackPeak Capital | Series B |
| FMR d.o.o. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 4, 2026
Open roles increased to 382, 2.2x the trailing average.
- Jul 20, 2026
Open roles increased to 377, 11.8x the trailing average.
For institutional investors. Book with your work email.
GenePlanet Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenePlanet's valuation, stock price, and market status.
Is GenePlanet a public or private company?
GenePlanet is a private company.
What is the current stock price of GenePlanet?
GenePlanet is a private company, so its shares have no public market price. Caplight tracks GenePlanet's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenePlanet worth (valuation)?
Valuation information for GenePlanet is not publicly available.
Can I buy GenePlanet stock?
GenePlanet shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenePlanet's last funding round?
GenePlanet's most recent funding round was Series B on July 13, 2023.
Who are the main investors in GenePlanet?
Key investors in GenePlanet include BlackPeak Capital.
Will GenePlanet IPO soon?
No public IPO plans have been announced for GenePlanet.
How can I track GenePlanet secondary market activity?
Caplight tracks bids, offers, and trades in GenePlanet's shares on secondary markets.